Pharmaceutical Technologies

The following section deals with manufacturing technologies of Pharmaceuticals and up-to-date pharmaceutical equipment

drug-development

FDA Policies on Drug Development Analyzed by Experts

The US Food and Drug Administration (FDA) heard from more than two dozen stakeholders on opportunities for the agency to promote more effective drug development programs at a public workshop at its he...
regeneron

Regeneron Pharmaceuticals Updated on Phase III Development Program of Libtayo®

Regeneron Pharmaceuticals, Inc. provided an update on the ongoing Phase 3 development program evaluating Libtayo® (cemiplimab), a PD-1 inhibitor, as monotherapy and combination therapy in first-line p...

The Russian Center for Precision Genome Editing Will Develop Drugs for Autoimmune Pathologies

The Russian Center for Precision Genome Editing and Genetic Technologies for Biomedicine, which has become one of the three centers for genomic research created within the framework of the national pr...
lab research

Avacta and ADC Therapeutics Join Forces to Develop Drug Conjugates

Pharma company Avacta Group PLC has signed a collaboration agreement with Swiss biotechnology firm ADC Therapeutics SA. Avacta’s lead candidate is Affimer, an alternative to antibodies, derived fro...

Innovent Biologics and Hutchison China MediTech Expand Global Collaboration Agreement

Innovent Biologics, Inc. and Hutchison China MediTech Limited announced the expansion of their global collaboration agreement to evaluate the safety and efficacy of Innovent’s Tyvyt® (sintilimab injec...

The Russian Export Center acted as BIOTECHMED 2019 General Partner

Global cooperation, international relations development and export of medical services were part of the agenda of the IV annual International Forum BIOTECHMED (September 16-17, Gelendzhik, Russia), tu...
drug development

Numab and Eisai Agreed to Discover and Develop Multi-Specific Antibody Immunotherapies for Cancer

Numab Therapeutics AG announced the initiation of a partnership with Eisai, Co., Ltd (Eisai), under a research and option agreement, to discover and develop novel multi-specific antibody immunotherapi...
drug-development

Chimerix Entered into Exclusive Global License Agreement with SymBio Pharmaceuticals

Chimerix, a development-stage biopharmaceutical company dedicated to accelerating the advancement of innovative medicines that make a meaningful impact in the lives of patients living with cancer and ...

Video

Expert opinion